Home Newsletters Immunology of Infectious Disease News Immunogenic and Efficacious SARS-CoV-2 Vaccine Based on Resistin-Trimerized Spike Antigen SmT1 and...

Immunogenic and Efficacious SARS-CoV-2 Vaccine Based on Resistin-Trimerized Spike Antigen SmT1 and SLA Archaeosome Adjuvant

By
Justin.choi
-
0
Researchers evaluated novel protein subunit vaccine formulations containing a resistin-trimerized spike antigen, SmT1.
[Scientific Reports]

Sorry, but the selected Zotpress account can't be found.

Full Article

RELATED ARTICLES

Exit mobile version